The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Antibiotic Resistance and New Antimicrobial drugs
Volume 14 - 2024 |
doi: 10.3389/fcimb.2024.1519737
This article is part of the Research Topic Advances in Infectious Disease Research: Tackling Antimicrobial Resistance, Zoonoses, and More View all 3 articles
Decoding MexB Efflux Pump Genes: Structural, Molecular and Phylogenetic Analysis of Multi Drug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa
Provisionally accepted- 1 Department of Biosciences, COMSATS University, Islamabad, 44000, Pakistan., ISLAMABAD, Pakistan
- 2 National Institute of Health (Pakistan), Islamabad, Islamabad, Pakistan
- 3 Department of Biology, College of Sciences, King Khalid University, Abha, Saudi Arabia, ABHA, Saudi Arabia
- 4 Department of Pathology, Viva Health Laboratories, New Lodge Drift Road, Windsor SL4 4RR United Kingdom, WINDSOR, United Kingdom
Emerging drug resistance in Pseudomonas aeruginosa is of great concern in clinical settings. P. aeruginosa activates its efflux-pump system in order to evade the effect of antibiotics. The current investigation aims to detect MexB genes in P. aeruginosa, their structural and molecular analysis and their impact on antimicrobial susceptibility profiling. A total of 42 clinical specimens were aseptically collected from hospitalized patients who had underlying infections related to medical implants. Matrix-assisted laser desorption ionization-time of flight (MALDI-ToF) were used for the identification of isolates. The methods used in this study were antibiotic susceptibility profiling, minimum inhibitory concentration (MIC), polymerase chain reaction (PCR), sanger sequencing, phylogenetic analysis, MolProbity score, Ramachandran plot analysis and multiple sequence alignment. The highest resistance was shown by P. aeruginosa against cefoperazone (67%), gentamycin and amikacin (66%) each, followed by cefotaxime (64%). The prevalence of multi-drug resistant (MDR) and extensively drug resistant (XDR) was 57% and 12%, respectively. The presence of an active efflux-pump system was indicated by the MexB genes found in most of the resistant isolates (p<0.05). Following addition of efflux pump inhibitor carbonyl cyanide m-chlorophenyl hydrazone (CCCP), a significant decrease (p<0.05) in MIC was observed in resistance, that revealed the presence of active efflux pump system. Phylogenetic analysis revealed evolutionary relationships with the P. aeruginosa strains isolated in Switzerland, Denmark and Germany. Protein domain architecture revealed that MexB gene proteins were involved in particular efflux pump function. Protein sequences aligned by multiple sequence alignment revealed conserved regions and sequence variants, which suggested antibiotic translocation and evolutionary divergence. These highly conserved regions could be used for diagnostic purposes of efflux pump MexB genes. To avoid their spread in hospital settings, responsible authorities ought to begin rigorous initiatives in order to reduce the prevalence of multi-drug resistant, extensively drug resistant, and efflux pump carrying isolates in clinical settings.
Keywords: Pseudomonas aeruginosa, antimicrobial resistance, efflux pump, Protein Dmoain, phylogenetic analysis, MolProbity, Ramachandran plot
Received: 30 Oct 2024; Accepted: 19 Dec 2024.
Copyright: © 2024 Habib, Shah, AMIR, ALGHAMDI, TARIQ, NISA and Ammoun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Naseer Ali Shah, Department of Biosciences, COMSATS University, Islamabad, 44000, Pakistan., ISLAMABAD, Pakistan
AFREENISH AMIR, National Institute of Health (Pakistan), Islamabad, Islamabad, Pakistan
HUDA AHMED ALGHAMDI, Department of Biology, College of Sciences, King Khalid University, Abha, Saudi Arabia, ABHA, Saudi Arabia
KIRAN NISA, Department of Biosciences, COMSATS University, Islamabad, 44000, Pakistan., ISLAMABAD, Pakistan
Marium Ammoun, Department of Pathology, Viva Health Laboratories, New Lodge Drift Road, Windsor SL4 4RR United Kingdom, WINDSOR, United Kingdom
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.